Alembic Pharmaceuticals receives an EIR for its oncology formulation facility BSE India May 6, 2024 According to the company’s statement, all EIRs are in place for their USFDA facilities
Lupin’s Somerset manufacturing plant receives EIR from US FDA EP News Bureau Jul 11, 2022 FDA changes inspection classification of Somerset facility to Voluntary Action Indicated (VAI)
